Articles
NANS Joins Coalition Urging Senate to Reinstate Medicare Payment Reform in Budget Bill
The North American Neuromodulation Society (NANS), alongside more than 70 leading medical organizations, has signed a joint letter urging the Senate to include a key Medicare payment provision from the House-passed One Big Beautiful Bill Act (H.R. 1) in its upcoming legislative package.
NANS and Partner Societies Urge Carelon to Reconsider Restrictive SCS Policy
The North American Neuromodulation Society (NANS), alongside several leading medical societies, has submitted a formal letter to Carelon Medical Benefits Management in response to its recent policy denying coverage for spinal cord stimulation (SCS) in patients with non-surgical low back pain.
NANS Responds to CMS Proposed FY26 Inpatient Rule
On Tuesday, June 10, NANS filed comments to CMS on the proposed rule setting forth proposed changes for the Medicare Hospital Inpatient Prospective Payment System (IPPS) for fiscal year (FY) 2026.
NANS Urges Humana to End Barriers to Peripheral Nerve Stimulation Access
NANS spearheaded a letter to Humana executives after members expressed serious concerns regarding ongoing prior authorization delays and denials for Peripheral Nerve Stimulation (PNS) treatments for Humana Medicare Advantage beneficiaries.
AMA Backs Permanent Medicare Payment Update as Key Step Toward Reform
The AMA strongly supports section 44304 of the Medicare proposal that provides a positive payment update of 75% of the Medicare Economic Index (MEI) for 2026.
NANS Joins with Leading Physician Groups to Urge NIH to Reevaluate Indirect Cost Policy
NANS joined over 40 medical organizations in a joint letter to the National Institutes of Health (NIH) expressing concerns over its new policy imposing a 15% cap on indirect cost rates for all NIH grants.
NANS Advocates for Protecting Intrathecal Pain Pumps
NANS joined 10 other societies to press Congress to amend the SUPPORT Act to protect access to intrathecal pain pumps. Specifically, the letter requests changes to the code by allowing direct dispensing of medication syringes to the prescribing physician or their designate and adding Schedule II medications to the list of approved schedules for these deliveries.
CMS Finalizes Payment Cuts for Physicians in 2025
On November 1, 2024, the Centers for Medicare & Medicaid Services (CMS) issued the final calendar year (CY) 2025 Physician Fee Schedule (PFS), which finalizes policies for physician payment and other outpatient services covered under Medicare Part B.
Humana Imposes Further Restrictions on Medicare Coverage for Neuromodulation Therapies
Open enrollment for Medicare Advantage runs October 15 – December 7. Physicians should be aware that Humana’s Medicare Advantage plan has some of the most rigorous and strict prior authorization requirements for neuromodulation therapies like spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS).
NANS, along with 11 medical societies, presses Humana on coverage for closed-loop SCS
Humana, Evicore, Cigna, and UPMC all had policies that characterized closed-loop SCS as “experimental, investigational and/or unproven.” NANS led efforts with the MPW to issue a letter to Humana, urging them to revise their policy.
NANS Comments on CMS CY 2025 Proposed Rule Making
The North American Neuromodulation Society (NANS) crafted a letter in response to the CMS Proposed Rule Making on revisions to Medicare payment policies under the Physician Payment Schedule (PFS) for calendar year (CY) 2025.
Updated HIPAA Privacy Rule Protects Reproductive Healthcare Privacy & Physician Resources
The U.S. Department of Health & Human Services Office of Civil Rights (OCR) has modified a Final Rule updating the HIPAA Privacy Rule. This rule prohibits the use or disclosure of reproductive protected health information (PHI) by covered entities and their business associates.